Literature DB >> 9138091

In vitro and in vivo expression of inducible nitric oxide synthase during experimental endotoxemia: involvement of other cytokines.

K Aono1, K Isobe, K Kiuchi, Z H Fan, M Ito, A Takeuchi, M Miyachi, I Nakashima, Y Nimura.   

Abstract

In this study, we investigated the expression of genes for inducible nitric oxide synthase (iNOS), tumor necrosis factor alpha (TNF-alpha), interleukin 1 beta (IL-1 beta), interleukin 6 (IL-6) of Kupffer cells in the presence of lipopolysaccharide (LPS), and the tissue expression of iNOS in a rat liver after LPS injection at various time intervals. The effects of L-NG-nitroarginine-methyl-esther HCI (L-NAME), a NO inhibitor, also were examined. The mRNA transcripts of TNF-alpha, IL-1 beta, and IL-6 were rapidly detected no more than at 1 h after LPS stimulation, whereas the iNOS transcript was detectable from 3 h after LPS stimulation and maximally increased at 12 h. This fact suggested that these early induced cytokines were related to expression of iNOS. Using an anti-iNOS antiserum raised against recombinant iNOS protein, immunohistochemical analysis was made to reveal kinetics of NO producing cells. The cells immunoreactive for iNOS appeared at 6 h post-LPS injection in the sinusoids of the liver. By structural and immunohistochemical studies, almost all iNOS positive cells were identified as Kupffer cells and endothelial cells. The number of cells immunoreactive for iNOS increased until 12 h post-LPS injection. At 24 h after LPS injection, iNOS positive cells were restricted to the foci of spotty necrosis. Hepatic injury measured by released enzymes was increased by pretreatment of L-NAME before LPS injection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9138091

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

1.  Effects of (20S*,24R*)-epoxy-9,19-cyclolanstane-3β,12β,16β,25-pentaol-3-O-β-D-xylopyranoside extracted from rhizoma Beesia on immunoregulation and anti-inflammation.

Authors:  Xian-Zhe Dong; Dai-Hong Guo; Ping Liu; Li-Hua Mu; Xiao-Yue Ge; Hong-Jie Li; Xiao-Li Zheng
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

2.  Temporal expression of tumor necrosis factor-alpha and nitric oxide synthase 2 in rat small intestine after endotoxin.

Authors:  R Arya; V B Grossie; N W Weisbrodt; M Lai; D Mailman; F Moody
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

3.  Nos2 deficiency enhances carbon tetrachloride-induced liver injury in aged mice.

Authors:  Deming Li; Yaping Song; Yahao Wang; Yuedong Guo; Zhaoke Zhang; Ganggang Yang; Gaiping Wang; Cunshuan Xu
Journal:  Iran J Basic Med Sci       Date:  2020-05       Impact factor: 2.699

4.  Insulin suppresses endotoxin-induced oxidative, nitrosative, and inflammatory stress in humans.

Authors:  Paresh Dandona; Husam Ghanim; Arindam Bandyopadhyay; Kelly Korzeniewski; Chang Ling Sia; Sandeep Dhindsa; Ajay Chaudhuri
Journal:  Diabetes Care       Date:  2010-08-10       Impact factor: 19.112

5.  Impaired liver regeneration in inducible nitric oxide synthasedeficient mice.

Authors:  R M Rai; F Y Lee; A Rosen; S Q Yang; H Z Lin; A Koteish; F Y Liew; C Zaragoza; C Lowenstein; A M Diehl
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

Review 6.  The molecular pathogenesis of cholestasis in sepsis.

Authors:  Harjit K Bhogal; Arun J Sanyal
Journal:  Front Biosci (Elite Ed)       Date:  2013-01-01

7.  Protective effect of phosphatidylcholine on lipopolysaccharide-induced acute inflammation in multiple organ injury.

Authors:  Yoon Yang Jung; Yunsung Nam; Yong Seol Park; Ho Sung Lee; Soon Auck Hong; Beom Keun Kim; Eon Sub Park; Yoon Hee Chung; Ji Hoon Jeong
Journal:  Korean J Physiol Pharmacol       Date:  2013-06-11       Impact factor: 2.016

8.  Anti-inflammatory and antioxidant effects of umbelliferone in chronic alcohol-fed rats.

Authors:  Mi-Ok Sim; Hae-In Lee; Ju Ri Ham; Kwon-Il Seo; Myung-Joo Kim; Mi-Kyung Lee
Journal:  Nutr Res Pract       Date:  2015-05-18       Impact factor: 1.926

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.